D'ANGELO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 3.405
AS - Asia 1.214
EU - Europa 889
SA - Sud America 130
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 29
OC - Oceania 3
Totale 5.784
Nazione #
US - Stati Uniti d'America 3.290
SG - Singapore 490
IT - Italia 240
CN - Cina 192
HK - Hong Kong 192
RU - Federazione Russa 182
VN - Vietnam 134
BD - Bangladesh 111
FR - Francia 107
BR - Brasile 94
CA - Canada 81
DE - Germania 64
GB - Regno Unito 63
FI - Finlandia 54
NL - Olanda 36
SE - Svezia 34
IN - India 28
PL - Polonia 24
UA - Ucraina 21
JP - Giappone 17
AR - Argentina 16
AT - Austria 14
ES - Italia 14
ZA - Sudafrica 12
IE - Irlanda 11
MX - Messico 9
TR - Turchia 8
EC - Ecuador 7
TT - Trinidad e Tobago 7
IL - Israele 5
LT - Lituania 5
TH - Thailandia 5
BE - Belgio 4
CH - Svizzera 4
CR - Costa Rica 4
JM - Giamaica 4
MY - Malesia 4
PK - Pakistan 4
SC - Seychelles 4
SV - El Salvador 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HN - Honduras 3
IQ - Iraq 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
ID - Indonesia 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 5.671
Città #
Ashburn 565
San Jose 497
Council Bluffs 430
Hong Kong 191
Singapore 121
Dallas 117
Fairfield 97
Beijing 89
The Dalles 80
Kent 75
Los Angeles 73
Moscow 69
Lauterbourg 68
New York 66
Helsinki 50
Dong Ket 48
Phoenix 44
Seattle 44
Chandler 43
Buffalo 42
Jacksonville 38
Santa Clara 38
Woodbridge 38
Wilmington 36
Toronto 34
Columbus 33
Houston 33
Boardman 32
Ho Chi Minh City 30
Cambridge 29
Keene 27
Chicago 23
Warsaw 23
Hanoi 21
Boston 19
Montreal 19
Amsterdam 18
Tokyo 17
Atlanta 16
Rome 16
Brooklyn 15
Chennai 15
Frankfurt am Main 15
London 15
Midlothian 15
Milan 14
Nuremberg 14
Orem 14
Dublin 12
Johannesburg 12
São Paulo 12
Princeton 11
Miami 10
Munich 10
Denver 9
North Bergen 9
Ann Arbor 8
Assago 8
Düsseldorf 8
Naples 8
Poplar 8
Porto Sant'elpidio 8
Stockholm 8
Tampa 8
Centro 7
Miano 7
Orlando 7
San Francisco 7
Vico Equense 7
Elk Grove Village 6
Montoro 6
San Diego 6
Venice 6
Ankara 5
Cancellara 5
Haiphong 5
Manchester 5
Austin 4
Bangkok 4
Brussels 4
Camerino 4
Cincinnati 4
Falkenstein 4
Mumbai 4
Salt Lake City 4
San José 4
San Salvador 4
Shanghai 4
Sterling 4
Taranto 4
Aprilia 3
Brasília 3
Buenos Aires 3
Chaguanas 3
Chiswick 3
City of London 3
Da Nang 3
Detroit 3
Florence 3
Fresno 3
Totale 3.776
Nome #
From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations 199
Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway 171
New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation 161
A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study 153
Correlation of Tumor Necrosis Factor-α −308G>A Polymorphism with Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences from an Italian Genetic Case–Control Study 140
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 124
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 115
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 107
TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study 105
Identification of a de novo NLRP3 gene variation in an Italian Behçet syndrome patient 101
ERAP1 molecular characterization: Identification of a de novo allelic variant 97
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 96
Harmonization of ANA testing challenge: quantification strategy to accurately predict end-point titers avoiding serial dilution 93
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review 93
Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging 92
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 90
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 89
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis 87
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences 86
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 86
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 83
Corticosteroid injection treatment for dactylitis in psoriatic arthritis 82
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 81
UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis 80
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 79
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 79
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 78
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 77
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 76
Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.) 71
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey 69
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 69
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 68
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 68
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 68
Prevalence of Type 2 and Type 1 Diabetes in Psoriatic Arthritis 66
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 66
The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis 65
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 63
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial 63
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 63
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 62
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 62
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 59
Morphologic, dynamic and high-resolution microscopy MRI in early-onset spondyloarthritis finger dactylitis 59
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 58
Serum amyloid A in healthy subjects: assessment of reference value using ELISA method 58
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 57
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 56
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 56
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study 55
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 55
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study 54
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients 54
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 54
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 52
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 52
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 51
The role of adalimumab in the treatment of heart block in HLA-B27-associated disease: a case description 51
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 51
Reply to the letter to the editor: Dynamic contrast-enhanced MRI could assess the local disease activity of enthesitis and dactylitis in patients with spondyloarthritis 46
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment 45
The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet’s syndrome: a large Italian cohort study 45
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 45
Understanding the Biological Significance of Anti-DFS70 Antibodies: Effect of Biologic Therapies on Their Occurrence in Inflammatory Arthritis 44
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 42
Toxicological considerations in the treatment of axial spondylo-arthritis 42
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment? 42
Impact of the COVID-19 Pandemic on the Appropriateness of Diagnostic Pathways of Autoimmune Rheumatic Diseases 42
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 41
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab 38
Real‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study 38
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 36
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie 35
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 33
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 30
The clinical profile of systemic sclerosis without a ‘scleroderma pattern’ at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology 27
Pregnancy and Behçet Syndrome: A Large Retrospective Italian Study 26
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults 21
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 20
Results of an expert Delphi consensus from the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Rheumatology (SIR) on standardized requesting and reporting magnetic resonance imaging in patients with suspected or known axial spondyloarthritis 20
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 19
Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry 19
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 18
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 17
When one joint matters: the monoarticular blind spot in inflammatory arthritis 17
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 17
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 15
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 14
The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study 13
Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion 12
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 10
Totale 5.784
Categoria #
all - tutte 30.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 18 7 5 13 7 10 4 0 19
2022/2023114 15 0 2 3 13 18 0 15 32 3 12 1
2023/202480 7 7 5 3 5 14 3 4 10 0 0 22
2024/20251.015 5 2 29 148 88 31 159 70 220 35 120 108
2025/20262.844 109 147 108 311 281 295 496 110 178 312 382 115
2026/20271.199 217 233 321 428 0 0 0 0 0 0 0 0
Totale 5.784